ALTHX — Thx Pharma SA Share News
0.000.00%
Last trade - 00:00Brief: Theranexus Reports Cash Position At Sept 30 Of 9.5 Million Euros
Brief: Theranexus H1 Net Loss Widens To Eur 2.8 Million
Brief: Theranexus Reports Inclusion Of Last Patient In Phase II Trial For THN102
Brief: Theranexus Announces Inclusion Of Last Subject In Its Phase IB Trial Of THN201
Brief: Theranexus: Realization Of Placement Of About 2.2 Million Euros
Brief: Theranexus Announces Launch Of Capital Increase
Brief: Theranexus Available Cash At End June EUR 10.2 Mln
Brief: Theranexus And BBDF Announce Agreement In Principle To Develop And Market Batten Disease Drug Candidate
Brief: Theranexus Announces Issuance Of Chinese Patent Covering Its Drug Candidate THN102
Brief: Theranexus FY Operating Loss Widens To 7.0 Million Euros
Brief: Theranexus Announces Research Collaboration With IRISA
Brief: Theranexus Announces Preliminary Results Of Phase II Trial Of THN102
Brief: Theranexus Cash Position On 31 December 2018 15.2 Million Euros
Brief: Theranexus Receives 6.2 Million Euros Funding Package
Brief: Theranexus Cash Position Of 15.8 Million Euros At 30 Sept.
Brief: Theranexus Announces Inclusion Of Last Patient In THN102 Phase II Trial
Brief: Theranexus Plans To Expand Its Phase II Pipeline With Third Program
Brief: Theranexus Receives European Patent Protecting THN201
Brief: Theranexus H1 Operating Loss Widens to 2.9 Million Euros